Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Evaluate the benefit of systematic appointment with a cardiologist a week after hospitalisation for acute heart failure. Randomised, endpoint: number of day alive out of hospital during 6 months
Background: the risk for rehospitalisation is very high after hospitalisation for acute heart failure. Aim: evaluate the benefit of a consultation with a cardiologist, including echocardiography and education of the patient, between 7 and 15 days after discharge, in high risk patients, identified with BNP or incomplete therapy. Parallel randomised study. The main endpoint is the number of day alive out of hospital during the 6 months post discharge; statistics intention to treat comparison of the number of days alive out of hospital in the group with consultation compared with the group without consultation. Recruitment 3 years and 4 months, follow-up 6 months. Patients included have been hospitalised in hospital BICHAT 75018 Paris, France. Financing is by the ministry of health (PHRQHOS)
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Control | No Intervention | usual care without systematic cardiology evaluation between 1 and 2 weeks | |
| Follow-up | Experimental | Evaluation by a cardiologist using echocardiography, completed by education of the patient if necessary |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Follow-up | Other | Evaluation by a cardiologist using echocardiography, completed by education of the patient if necessary |
|
| Measure | Description | Time Frame |
|---|---|---|
| days alive out of hospital 6 months post discharge | 6 months |
| Measure | Description | Time Frame |
|---|---|---|
| rehospitalisation rate at 6 months | 6 months | |
| mortality at 3 and 6 months | 3 and 6 months | |
| number of patients receiving beta-blocker at 6 months |
Not provided
Criteria of inclusion :
Criteria of not inclusion :
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Guillaume JONDEAU, MD, PHD | Assistance Publique - Hôpitaux de Paris | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Hopital Bichat Claude Bernard | Paris | 75018 | France |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| 6 months |
| number of patients receiving a ACEI at 6 months | 6 months |
| QOL at 6 months | 6 months |
| autoevaluation of improvement/alteration of the patient state at 6 months | 6 months |
| number of patients receiving beta-blocker at 3 months | 3 months |
| number of patients receiving a ACEI at 3 months | 3 months |
| QOL at 3 months | 3 months |
| autoevaluation of improvement/alteration of the patient state at 3 months | 3 months |
| number of patients having an optimal treatment at 6 months | 6 months |
| number of patients having an optimal treatment at 3 months | 3 months |